Establishing the Suitability of Model-Integrated Evidence to Demonstrate Bioequivalence for Long-Acting Injectable and Implantable Drug Products public workshop image

Join the Center for Research on Complex Generics and FDA for the Establishing the Suitability of Model-Integrated Evidence to Demonstrate Bioequivalence for Long-Acting Injectable and Implantable Drug Products public workshop, from 8:30 a.m. to 5:30 p.m. Nov. 30, 2021.

 

This workshop is FREE.

For more information and to register, click here.

 

 

Students, faculty, and staff, let your voice be heard!
Submit Your Story.